Tam, M., & Bhabhra, R. (2020). MON-338 Severe Hypophosphatemia Induced by Intravenous Ferric Carboxymaltose Therapy for Iron Deficiency Anemia. J Endocr Soc.
Chicago Style CitationTam, Matthew, i Ruchi Bhabhra. "MON-338 Severe Hypophosphatemia Induced By Intravenous Ferric Carboxymaltose Therapy for Iron Deficiency Anemia." J Endocr Soc 2020.
Cita MLATam, Matthew, i Ruchi Bhabhra. "MON-338 Severe Hypophosphatemia Induced By Intravenous Ferric Carboxymaltose Therapy for Iron Deficiency Anemia." J Endocr Soc 2020.
Atenció: Aquestes cites poden no estar 100% correctes.